Corporate News

Result of Annual General Meeting

06 July 2017

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, is pleased to announce that at the Company's Annual General Meeting held earlier today, 6 July 2017, all resolutions put to the meeting were duly passed.


For further information:

Quantum Pharma Plc  
Chris Rigg, Chief Executive Officer Tel: +44 (0) 1207 279 404
Gerard Murray, Chief Financial Officer  
N+1 Singer
(Nominated Advisor & Broker)
Sandy Fraser / Nick Owen / James White Tel: +44 (0) 20 7496 3000
Media enquiries:  
Henry Harrison-Topham / Sophie Cowles Tel: +44 (0) 20 7466 5000


Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.

For further information, please visit


back to top

back to Corporate News


Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products